Home › Hereditary Angioedemas › New York
Hereditary Angioedemas clinical trials in New York
3 studies for Hereditary Angioedemas are looking for participants at sites in New York.
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
- ADARx Clinical Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06960213Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
- ADARx Clinical Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07428499Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
- Montefiore Medical Center, The Bronx
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Feb 27, 2026 · NCT06919003From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.